|
|
Yoshihiro Kamada, Hiroyuki Nagaretani, Shinji Tamura, Tohru Ohama, Takao Maruyama, Hisatoyo Hiraoka, Shizuya Yamashita, Akira Yamada, Shinichi Kiso, Yoshiaki Inui, Nobuyuki Ito, Yoshiro Kayanoki, Sumio Kawata, Yuji Matsuzawa
J Clin Invest. 2001;
108(5):717
doi:10.1172/JCI11260
Abstract |
Full text
| PDF

A
lthough L-arginine is the only substrate for nitric oxide (NO) production, no studies have yet been reported on the effect of an L-arginine deficiency on vascular function in humans. Lysinuric protein intolerance (LPI) is a rare autosomal recessive defect of dibasic amino acid transport caused by mutations in the SLC7A7 gene, resulting in an L-arginine deficiency. Vascular endothelial function was examined in an LPI patient who was shown to be a compound heterozygote for two mutations in the gene (5.3-kbp Alu-mediated deletion, IVS3+1G→Α). The lumen diameter of the brachial artery was measured in this patient and in healthy controls at rest, during reactive hyperemia (endothelium-dependent vasodilation [EDV]), and after sublingual nitroglycerin administration (endothelium-independent vasodilation [EIV]) using ultrasonography. Both EDV and NOx concentrations were markedly reduced in the patient compared with those for the controls. They became normal after an L-arginine infusion. EIV was not significantly different between the patient and controls. Positron emission tomography of the heart and a treadmill test revealed ischemic changes in the patient, which were improved by the L-arginine infusion. Thus, in the LPI patient, L-arginine deficiency caused vascular endothelial dysfunction via a decrease in NO production.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(8)
| Title and authors |
Publication |
Year |
Lysinuric protein intolerance: update and extended mutation analysis of theSLC7A7 gene
Maria Pia Sperandeo, Generoso Andria, Gianfranco Sebastio
|
Hum. Mutat.
|
2008 |
New Strategies for the Treatment of Pulmonary Hypertension in Sickle Cell Disease
Claudia R Morris
|
Treatments in Respiratory Medicine
|
2006 |
Nitric oxide insufficiency and atherothrombosis
Barbara Voetsch, Richard C. Jin, Joseph Loscalzo
|
Histochem Cell Biol
|
2004 |
Protective role of endothelial nitric oxide synthase
Ester WJA Albrecht, Coen A Stegeman, Peter Heeringa, Rob H Henning, Harry van Goor
|
J. Pathol.
|
2003 |
Transport of l-arginine and nitric oxide formation in human platelets
Maria G. Signorello, Raffaele Pascale, Giuliana Leoncini
|
Eur J Biochem
|
2003 |
REGULATION OFNITRICOXIDESYNTHESIS BYDIETARYFACTORS
Guoyao Wu, Cynthia J. Meininger
|
Annu. Rev. Nutr.
|
2002 |
Five novelSLC7A7 variants and y+L gene-expression pattern in cultured lymphoblasts from Japanese patients with lysinuric protein intolerance
Yutaka Shoji, Atsuko Noguchi, Yasuko Shoji, Mika Matsumori, Yuhei Takasago, Masaki Takayanagi, Yoshihiro Yoshida, Kenji Ihara, Toshiro Hara, Shuichi Yamaguchi, Makoto Yoshino, Masayuki Kaji, Shigenori Yamamoto, Akio Nakai, Akio Koizumi, Youichi Hokezu, Keiji Nagamatsu, Hitoshi Mikami, Isao Kitajima, Goro Takada
|
Hum. Mutat.
|
2002 |
The arginine paradox.
Toshio NAKAKI, Keiichi HISHIKAWA
|
Folia Pharmacol. Jpn.
|
2002 |
|